Lv, Zhongyue
Li, Ying
Wang, Yachen
Cong, Fengyu
Li, Xiaoyan
Cui, Wanming
Han, Chao
Wei, Yushan
Hong, Xiaojun
Liu, Yong
Ma, Luyi
Jiao, Yang
Zhang, Chi
Li, Huanjie
Jin, Mingyan
Wang, Liang
Ni, Shiwei
Liu, Jing http://orcid.org/0000-0002-0493-296X
Funding for this research was provided by:
Program of the China National Health Commission and National Medical Products Administration (CMR-20161129-1003)
National Natural Science Foundation of China (81471308, 81802819, 82072953)
Liaoning Province Excellent Talent Program Project (XLYC1902031)
Dalian Science and Technology Innovation Fund (2018J11CY025)
Top young talents of Liaoning Provincial Government (XLYC1907009)
National Defense Science and Technology Innovation Fund of China (19-163-00-KX-003-001-01)
Article History
Received: 27 April 2022
Accepted: 5 June 2022
First Online: 9 February 2023
Declarations
:
: The study “Clinical research of neural stem cells in the treatment of children with cerebral palsy” was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University on Dec 2nd, 2016. The reference number of the ethics approval was LCKY2016-60. The review of the Ethics amendment was also approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University on Apr 2nd, 2017. The comment number was YJ-KS-KY-2017–09. There were no ethical conflicts in this manuscript. The Ethics Committee of the First Affiliated Hospital of Dalian Medical University declared no ethical concerns. The procedures were fully explained to the participants and their guardians. All the participants’ guardians voluntarily signed informed consent before participating.
: Not applicable.
: The authors declare that they have no competing interests.